Coralie Goetz

Coralie Goetz

Auto-generated profile, based on publicly available information

Coralie Goetz

Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, Quebec, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
CDCarine Diarra
Carine Diarra
CGCoralie Goetz
Coralie Goetz
MGMérilie Gagnon
Mérilie Gagnon
DRDenis Roy
Denis Roy
JJJulie Jean
Julie Jean
In the food industry, especially dairy, biofilms can be formed by heat-resistant spoilage and pathogenic bacteria from the farm. Such biofilms may persist throughout the processing chain and contaminate milk and dairy products continuously, increasing equipment cleaning, maintenance costs, and product recalls. Most biofilms are multispecies, yet most studies focus on single-species models. A multispecies model of dairy biofilm was developed under static and dynamic conditions using heat-resistant Bacillus licheniformis, Pseudomonas aeruginosa, Clostridium tyrobutyricum, Enterococcus faecalis, Streptococcus thermophilus, and Rothia kristinae isolated from dairies. C. tyrobutiricum and R. kristinae were weak producers of biofilm, whereas the other four were moderate to strong producers. Based on cross-streaking on agar, P. aeruginosa was found to inhibit B. licheniformis and E. faecalis . In multispecies biofilm formed on stainless steel in a CDC reactor fed microfiltered milk, the strong biofilm producers were dominant while the weak producers were barely detectable. All biofilm matrices were dispersed easily by proteinase K treatment but were less sensitive to DNase or carbohydrases. Further studies are needed to deepen our understanding of multispecies biofilms and interactions within to develop improved preventive strategies to control the proliferation of spoilage and pathogenic bacteria in dairies and other food processing environments. IMPORTANCE: A model of multispecies biofilm was created to study biofilm formation by heat-resistant bacteria in the dairy industry. The biofilm formation potential was evaluated under static conditions. A continuous flow version was then developed to study multispecies biofilm formed on stainless steel in microfiltered milk under dynamic conditions encountered in dairy processing equipment. The study of biofilm composition and bacterial interactions therein will lead to more effective means of suppressing bacterial growth on food processing equipment and contamination of products with spoilage and pathogenic bacteria, which represent considerable economic loss.

1 August 2025 in Journal of Dairy Science
Verified
Journal Article
Open access
CGCoralie Goetz
Coralie Goetz
LSLaurie Sanschagrin
Laurie Sanschagrin
EJEric Jubinville
Eric Jubinville
MJMario Jacques
Mario Jacques
JJJulie Jean
Julie Jean
Biofilm formation allows microorganisms including bacteria to persist on abiotic or biotic surfaces, to resist treatments with biocides (disinfectants and antibiotics) and to evade the immune response in animal hosts much more than they do in the planktonic form. Bacteria able to form biofilm can be troublesome in the dairy industry, both by causing clinical symptoms in livestock and by colonizing milking devices and milk processing equipment, resulting in dairy products of lower quality and sometimes raising serious food safety issues. In fact, most of the bacterial species isolated frequently in the dairy chain have the ability to form biofilm. Common examples include Staphylococcus aureus and other staphylococci that frequently infect mammary glands, but also Bacillus spp., Listeria monocytogenes and Pseudomonas spp. which cause spoilage of dairy products and sometimes foodborne illnesses. The economic losses due to biofilm formation in the dairy industry are considerable, and scientists are constantly solicited to develop new antibiofilm strategies, especially using biocides of natural origin. Although the number of studies in this subject area has exploded in recent years, the in vivo efficacy of most novel approaches remains to be explored. Used alone or to increase the efficacy of disinfectants or antibiotics, they could allow the implementation of strategies having less impact on the environment. Their use is expected to lead to less reliance on antibiotics to treat intramammary infections in dairy farms and to the use of lower concentrations of chemical disinfectants in dairy processing plants.

2 June 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
IDIbtissem Doghri
Ibtissem Doghri
TCTamazight Cherifi
Tamazight Cherifi
CGCoralie Goetz
Coralie Goetz
FMFrançois Malouin
François Malouin
MJMario Jacques
Mario Jacques
PFPhilippe Fravalo
Philippe Fravalo
Listeria monocytogenes (L. monocytogenes) is often associated with processed food as it can form biofilms that represent a source of contamination at all stages of the manufacturing chain. The control and prevention of biofilms in food-processing plants are of utmost importance. This study explores the efficacy of prospect molecules for counteracting bacterial mechanisms leading to biofilm formation. The compounds included the phytomolecule tomatidine, zinc chloride (ZnCl2), ethylenediaminetetraacetic acid (EDTA), and a more complexed mixture of bacterial compounds from coagulase-negative staphylococci (CNS exoproducts). Significant inhibition of L. monocytogenes biofilm formation was evidenced using a microfluidic system and confocal microscopic analyses (p < 0.001). Active molecules were effective at an early stage of biofilm development (≥50% of inhibition) but failed to disperse mature biofilms of L. monocytogenes. According to our findings, prevention of surface attachment was associated with a disruption of bacterial motility. Indeed, agar cell motility assays demonstrated the effectiveness of these molecules. Overall, results highlighted the critical role of motility in biofilm formation and allow to consider flagellum-mediated motility as a promising molecular target in control strategies against L. monocytogenes in food processing environments.

14 May 2024 in Beneficial Microbes
Verified
Journal Article
Open access
PDF file
CGC. Goetz
C. Goetz
LRL. Rault
L. Rault
JCJ. Cuffel
J. Cuffel
PPP. Poton
P. Poton
LFL. Finot
L. Finot
SESergine Even
Sergine Even
Bovine mastitis (BM) is a major disease in dairy industry. The current approaches – mainly antibiotic treatments – are not entirely effective and may contribute to antimicrobial resistance dissemination, rising the need for alternative treatment. The present study aims to evaluate the impact of post-milking application of Lacticaseibacillus paracasei CIRM BIA 1542 (Lp1542) on the teat skin (TS) of 20 Holstein cows in mid lactation, in order to reinforce the barrier effect of the microbiota naturally present on the teat. Treatment (Lp1542, iodine or no treatment) was applied post-milking twice a day on the 4 teats of healthy animals for 15 days. Blood and milk samples, and TS swabs were collected at day (D)1, D8, D15 and D26 before morning milking and at D15 before evening milking (D15E) to evaluate Lp1542 impact at the microbial, immune and physiological levels. Lp1542 treatment resulted in a higher lactic acid bacteria and total microbial populations on TS and in foremilk (FM) at D15(E) compared with iodine treatment. Metabarcoding analysis revealed changes in the composition of TS and FM microbiota, beyond a higher Lacticaseibacillus abundance. This included a higher abundance of Actinobacteriota, including Bifidobacterium, and a lower abundance of Pseudomonadota on TS of Lp1542 compared with iodine-treated quarters. In addition, Lp1542 treatment did not trigger any major inflammatory response in the mammary gland, except interleukin 8 production and expression which tended to be slightly higher in Lp1542-treated cows compared with the others. Finally, Lp1542 treatment had no impact on the mammary epithelium functionality (milk yield and composition) and integrity (epithelial cell exfoliation into milk and milk Na+/K+ ratio). Altogether, these results indicate that a topical treatment with Lp1542 is safe with regard to mammary gland physiology and immune system, while impacting its microbiota, inviting us to further explore its effectiveness for mastitis prevention.

27 July 2020
Verified
Conference Paper
Open access
CGCoralie Goetz
Coralie Goetz
NNNissa Niboucha
Nissa Niboucha
JJJulie Jean
Julie Jean
The ability of microorganisms to form biofilms has become a major problem in the dairy industry in Canada, notably by affecting the quality and the safety of the by-products. Established biofilms are difficult to remove during the CIP cleaning system and may become resistant to sanitizers. Therefore, it is important to identify and characterize the microorganisms associated to biofilm in the Canadian dairy industry, allowing to develop improvement strategies of biofilm control. The purpose of this study is to evaluate the ability to form biofilms by spoilage microorganisms isolated in processing plants in Canada. For this purpose, 19 strains were isolated from problems associated with the formation of biofilms in the dairy industry and identified using a MALDI-TOF mass spectrometer. The single species biofilm production of these isolates was then measured after a crystal violet coloration using 96-well microplates. The results revealed different biofilm formation profiles depending of the isolates in culture medium. Indeed, 7/19 isolates are moderate or strong biofilm producers and 12/19 isolates are negative or weak biofilm producers. Furthermore, enzymatic treatments revealed that the composition of the biofilms was different depending of the species but also the isolates. In conclusion, the results suggest that some of the isolates collected in the dairy industry have the ability to produce moderate or strong biofilms and thus, to facilitate the persistence of other spoilage microorganisms but also potential pathogenic microorganisms such as Listeria monocytogenes. The characterization of those biofilms will be helpful to the development of an effective approach allowing a better control of the biofilms in the dairy industry.

30 June 2026 in PLOS ONE
Verified
Journal Article
Open access
CGCoralie Goetz
Coralie Goetz
IDIbtissem Doghri
Ibtissem Doghri
SDSneha Das
Sneha Das
ACAudrey Corbeil
Audrey Corbeil
PBPauline Bouveret
Pauline Bouveret
FMFrançois Malouin
François Malouin
Bacterial biofilms are structured communities of bacterial cells enclosed in a self-produced polymeric matrix, which can adhere to biotic or abiotic surfaces. This mode of existence permits these bacteria to endure in adverse conditions, including the presence of antibiotics Bacteria within biofilms are responsible for numerous infections in humans and animals, including bovine mastitis. It is therefore important to develop new therapeutic strategies to control and treat biofilm-associated infections. The results obtained by our group during the study of mixed bacterial biofilm communities showed that four isolates of coagulase-negative staphylococci (CNS; two Staphylococcus chromogenes and two Staphylococcus simulans ) that produce only a small amount of biofilm can significantly reduce biofilm formation in approximatively 80% of pathogenic staphylococci associated with bovine mastitis. Furthermore, supernatants of S. chromogenes reduced secondary intramammary colonization by S. aureus in a murine model of mastitis. However, information regarding the mechanism and the effector molecule(s) involved is lacking. The objective of this study was therefore to investigate and characterize the antibiofilm molecule(s) produced by these four CNS isolates. In this context, we prepared culture supernatants from two isolates of S. chromogenes (C and E) and two isolates of S. simulans (F and H) to evaluate their effect on biofilm production of pathogenic bacterial species involved in bovine mastitis. Using a standard biofilm microtiter plate assay, we demonstrated that the four CNS supernatants not only have a significant impact on biofilms of pathogenic staphylococci (68% of tested isolates) but also on those of other important mastitis pathogens such as Streptococcus spp., Trueperella pyogenes , Klebsiella spp. and Escherichia coli (61.3% of tested isolates) . The isolation and characterization of the antibiofilm molecule(s) contained in the supernatants were then conducted using a filtration process with membranes of different porosities, as well as through physicochemical and enzymatic treatments. We were then able to confirm that antibiofilm activity against staphylococci was present in the < 3kDa fractions of CNS culture supernatants and that this activity was heat-stable and protease-resistant, but sensitive to RNase A, suggesting that the antibiofilm activity might be due, at least in part, to an RNA molecule. Preliminary results showed that the antibiofilm activity was maintained with RNA extracts from fractioned supernatants (<3kDa). In conclusion, these results confirmed that some CNS have an antibiofilm activity, which represents a promising new avenue in the fight against biofilm-associated infections, particularly bovine mastitis.